I have had a good think about the results "being at the low end of the quality spectrum", because if you look at the charts it doesn't look all that impressive.
But I think you have to take into consideration these people are older and the drug was acting to "fix damage" rather than prevent/minimise damage which should be a more effective
The trial was short when you consider it is about the brain. Brains learn/change very slowly, so even subtle changes can be considered huge.
Observing..., page-6
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |